Neal Hanchard leads a study of genomes from Africa.
The Euro obsession with race has obscured the fact that humans are one species with a lot of regional diversity resulting from migrations out of Africa over the last 100.000 years. BUT .. what about diversity IN AFRICA?
A report issued at the annual meeting of the American Society of Human Genetics announced that genome sequences from across more than a dozen African countries and 426 African people have now been acquired. More than 3 million genetic variations were found that have not been seen in European genomes. The most exciting are linked to infectious disease and viral infection.
This is likely just the beginning. As Dr. Hanchard’s biography states, we have lots of reasons to believe that genetics plays a huge role in the outcomes of longstanding diseases in Africa .. from sickle, to TB to malnutrition.
The promise of this work is immense not only for Africans but for all humans. The scientific session where the work was presented was headed by Kiran Musunuru, an exciting young associate professor at the University of Pennsylvania.
Musunuru’s work is my field, that is cardiovascular disease. He crosses disciplines ranging from the sort of population genetics described by Neal Hanchard to stem cell biology and the use of genome editing to correct genetic errors.
Gene editing is not likely to come to Africa soon but Hanchard’s work illustrates why data from the wonderful, ancient African genome is important for us all as a way of identifying the sites in the genome where genome therapy or new drugs may be effective for all humans.
There is one more reason why I found this study exciting. Reading the comments by Dr. Musunuru about the genetics of Africa made me curious about his own work. I looked him up in Medline* and discovered that Kiran Mususnuru is an outstanding scientist.. But the name “Mususnuru” itself intrigued me.
I had, correctly, assumed that Neal Hanchard was of African ancestry based on interts and appearnce. From his appearance I had first assumed that Dr. Mususnuru was also of African or African American ancestry. I did not find any information on his family on the web but after I researched the name I now assume Dr. Mususnuru’s ancestors must have come from the province of India with the same name on the west coast of India. Thousands or tens of thousands years ago, the emigrants from Africa must have passed through what is now the “Musunuru” mandal (subdistrict) in the Krishna district of the state of Andhra Pradesh. Assuming my assumption about his name is correct, it is hard to not imagine that Kiran Masunuru is now using Dr. Hanchard’s data to look at the ancient African origins of his own family. It would be amazing if some of these genes were not represented in genetic loci that explain heritability of cardiovascular and other diseases in India.
India has also begun a genomics study.
This paper may be as important as Genesis in telling us the origins of humanity and giving us new tools that benefit all humans.
READMORE
Partial Bibliogrpahy of Kiran Musunuru
1: Patel N, Russell GK, Musunuru K, Gutierrez OM, Halade GV, Kain V, Lv W, Prabhu SD, Margulies KB, Cappola TP, Arora G, Wang TJ, Arora P. Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial. Circ Res. 2019 Oct
6. doi: 10.1161/CIRCRESAHA.119.315026. [Epub ahead of print] PubMed PMID:
31588864.
2: Corbin EA, Vite A, Peyster EG, Bhoopalam M, Brandimarto J, Wang X, Bennett AI,
Clark AT, Cheng X, Turner KT, Musunuru K, Margulies KB. Tunable and Reversible
Substrate Stiffness Reveals a Dynamic Mechanosensitivity of Cardiomyocytes. ACS
Appl Mater Interfaces. 2019 Jun 12;11(23):20603-20614. doi:
10.1021/acsami.9b02446. Epub 2019 May 30. PubMed PMID: 31074953.
3: Morley MP, Wang X, Hu R, Brandimarto J, Tucker NR, Felix JF, Smith NL, van der
Harst P, Ellinor PT, Margulies KB, Musunuru K, Cappola TP. Cardioprotective
Effects of MTSS1 Enhancer Variants. Circulation. 2019 Apr 23;139(17):2073-2076.
doi: 10.1161/CIRCULATIONAHA.118.037939. PubMed PMID: 31070942; PubMed Central
PMCID: PMC6510256.
4: Alapati D, Zacharias WJ, Hartman HA, Rossidis AC, Stratigis JD, Ahn NJ, Coons
B, Zhou S, Li H, Singh K, Katzen J, Tomer Y, Chadwick AC, Musunuru K, Beers MF,
Morrisey EE, Peranteau WH. In utero gene editing for monogenic lung disease. Sci
Transl Med. 2019 Apr 17;11(488). pii: eaav8375. doi:
10.1126/scitranslmed.aav8375. PubMed PMID: 30996081.
5: Musunuru K, Kathiresan S. Genetics of Common, Complex Coronary Artery Disease.
Cell. 2019 Mar 21;177(1):132-145. doi: 10.1016/j.cell.2019.02.015. Review. PubMed
PMID: 30901535.
6: Stellos K, Musunuru K. Scientists on the Spot: The future of genome editing in
cardiovascular medicine. Cardiovasc Res. 2019 Feb 1;115(2):e20-e21. doi:
10.1093/cvr/cvy302. PubMed PMID: 30668681.
7: Lv W, Qiao L, Petrenko N, Li W, Owens AT, McDermott-Roe C, Musunuru K.
Functional Annotation of TNNT2 Variants of Uncertain Significance With
Genome-Edited Cardiomyocytes. Circulation. 2018 Dec 11;138(24):2852-2854. doi:
10.1161/CIRCULATIONAHA.118.035028. PubMed PMID: 30565988; PubMed Central PMCID:
PMC6309910.
8: Wang X, Musunuru K. Confirmation of Causal rs9349379- PHACTR1 Expression
Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial
Cells. Circ Genom Precis Med. 2018 Oct;11(10):e002327. doi:
10.1161/CIRCGEN.118.002327. PubMed PMID: 30354304; PubMed Central PMCID:
PMC6211814.
9: Lin J, Musunuru K. From Genotype to Phenotype: A Primer on the Functional
Follow-up of Genome-Wide Association Studies in Cardiovascular Disease. Circ
Genom Precis Med. 2018 Feb;11(2). pii: e001946. Epub 2018 Jan 30. PubMed PMID:
29915816; PubMed Central PMCID: PMC6003539.
10: Musunuru K. How genome editing could be used in the treatment of
cardiovascular diseases. Per Med. 2018 Mar;15(2):67-69. doi:
10.2217/pme-2017-0078. Epub 2018 Feb 2. PubMed PMID: 29714123.
11: Chadwick AC, Evitt NH, Lv W, Musunuru K. Reduced Blood Lipid Levels With In
Vivo CRISPR-Cas9 Base Editing of ANGPTL3. Circulation. 2018 Feb
27;137(9):975-977. doi: 10.1161/CIRCULATIONAHA.117.031335. PubMed PMID: 29483174;
PubMed Central PMCID: PMC5830171.
12: Musunuru K. Stem cell modeling of lipid genetics. Curr Opin Lipidol. 2018
Apr;29(2):151-155. doi: 10.1097/MOL.0000000000000490. Review. PubMed PMID:
29351105.
13: Zezulin A, Musunuru K. Turning up the Heat with Therapeutic Epigenome
Editing. Cell Stem Cell. 2018 Jan 4;22(1):10-11. doi: 10.1016/j.stem.2017.12.013.
PubMed PMID: 29304336.
14: Musunuru K. Genome Editing: The Recent History and Perspective in
Cardiovascular Diseases. J Am Coll Cardiol. 2017 Dec 5;70(22):2808-2821. doi:
10.1016/j.jacc.2017.10.002. Review. PubMed PMID: 29191331; PubMed Central PMCID:
PMC5742864.
15: Rohacek AM, Bebee TW, Tilton RK, Radens CM, McDermott-Roe C, Peart N, Kaur M,
Zaykaner M, Cieply B, Musunuru K, Barash Y, Germiller JA, Krantz ID, Carstens RP,
Epstein DJ. ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative
Splicing that Disrupt Cochlear Development. Dev Cell. 2017 Nov
6;43(3):318-331.e5. doi: 10.1016/j.devcel.2017.09.026. Epub 2017 Oct 26. PubMed
PMID: 29107558; PubMed Central PMCID: PMC5687886.
16: Wang X, Raghavan A, Peters DT, Pashos EE, Rader DJ, Musunuru K. Interrogation
of the Atherosclerosis-Associated SORT1 (Sortilin 1) Locus With Primary Human
Hepatocytes, Induced Pluripotent Stem Cell-Hepatocytes, and Locus-Humanized Mice.
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):76-82. doi:
10.1161/ATVBAHA.117.310103. Epub 2017 Nov 2. PubMed PMID: 29097363; PubMed
Central PMCID: PMC5746470.
17: Musunuru K, Lagor WR, Miano JM. What Do We Really Think About Human Germline
Genome Editing, and What Does It Mean for Medicine? Circ Cardiovasc Genet. 2017
Oct;10(5). pii: e001910. doi: 10.1161/CIRCGENETICS.117.001910. PubMed PMID:
28974517; PubMed Central PMCID: PMC5658039.
18: Chadwick AC, Wang X, Musunuru K. In Vivo Base Editing of PCSK9 (Proprotein
Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome
Editing. Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1741-1747. doi:
10.1161/ATVBAHA.117.309881. Epub 2017 Jul 27. PubMed PMID: 28751571; PubMed
Central PMCID: PMC5570639.
19: Musunuru K, Kathiresan S. Cardiovascular endocrinology: Is ANGPTL3 the next
PCSK9? Nat Rev Endocrinol. 2017 Sep;13(9):503-504. doi: 10.1038/nrendo.2017.88.
Epub 2017 Jul 14. PubMed PMID: 28707678.
20: Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A,
Herbst A, Northoff BH, Nicolaou A, Gäbel G, Beutner F, Scholz M, Thiery J,
Musunuru K, Krohn K, Mann M, Teupser D. Circular non-coding RNA ANRIL modulates
ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016 Aug
19;7:12429. doi: 10.1038/ncomms12429. PubMed PMID: 27539542; PubMed Central
PMCID: PMC4992165.
21: Lin J, Musunuru K. Genome engineering tools for building cellular models of
disease. FEBS J. 2016 Sep;283(17):3222-31. doi: 10.1111/febs.13763. Epub 2016 Jun
22. Review. PubMed PMID: 27218233; PubMed Central PMCID: PMC5881911.
22: Musunuru K, Kathiresan S. Surprises From Genetic Analyses of Lipid Risk
Factors for Atherosclerosis. Circ Res. 2016 Feb 19;118(4):579-85. doi:
10.1161/CIRCRESAHA.115.306398. Review. PubMed PMID: 26892959; PubMed Central
PMCID: PMC4762058.
23: Strong A, Musunuru K. (Pro)renin Receptor and LDL Clearance: An Old Player
Joins A New Game. Circ Res. 2016 Jan 22;118(2):187-9. doi:
10.1161/CIRCRESAHA.115.308068. PubMed PMID: 26838309; PubMed Central PMCID:
PMC4743896.
24: Gupta RM, Meissner TB, Cowan CA, Musunuru K. Genome-Edited Human Pluripotent
Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport–Brief
Report. Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):15-8. doi:
10.1161/ATVBAHA.115.305956. Epub 2015 Nov 5. PubMed PMID: 26543098; PubMed
Central PMCID: PMC4690765.
25: Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad AF, Li MK,
Hughes MR, Werff RV, Peters DT, Lu J, Baccei A, Siedlecki AM, Valerius MT,
Musunuru K, McNagny KM, Steinman TI, Zhou J, Lerou PH, Bonventre JV. Modelling
kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent
epiblast spheroids. Nat Commun. 2015 Oct 23;6:8715. doi: 10.1038/ncomms9715.
PubMed PMID: 26493500; PubMed Central PMCID: PMC4620584.
26: Musunuru K. Genome editing of a CArG element in the mouse genome establishes
its role in gene expression. Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):496-7.
doi: 10.1161/ATVBAHA.115.305175. PubMed PMID: 25717176.
27: Gupta RM, Musunuru K. Expanding the genetic editing tool kit: ZFNs, TALENs,
and CRISPR-Cas9. J Clin Invest. 2014 Oct;124(10):4154-61. doi: 10.1172/JCI72992.
Epub 2014 Oct 1. Review. PubMed PMID: 25271723; PubMed Central PMCID: PMC4191047.
28: Veres A, Gosis BS, Ding Q, Collins R, Ragavendran A, Brand H, Erdin S, Cowan
CA, Talkowski ME, Musunuru K. Low incidence of off-target mutations in individual
CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome
sequencing. Cell Stem Cell. 2014 Jul 3;15(1):27-30. doi:
10.1016/j.stem.2014.04.020. Erratum in: Cell Stem Cell. 2014 Aug 7;15(2):254.
Cowan, Chad A [added]. PubMed PMID: 24996167; PubMed Central PMCID: PMC4082799.
29: Chaturvedi S, Musunuru K. The Stroke Genetics Network: living up to its
potential. Stroke. 2013 Oct;44(10):2679. doi: 10.1161/STROKEAHA.113.002693. Epub
2013 Sep 10. PubMed PMID: 24021685.
30: Musunuru K. Identification of a growth factor that rejuvenates the heart.
Circ Cardiovasc Genet. 2013 Aug;6(4):435-6. doi: 10.1161/CIRCGENETICS.113.000274.
PubMed PMID: 23963162.
31: Musunuru K. Enduring mystery of the chromosome 9p21.3 locus. Circ Cardiovasc
Genet. 2013 Apr;6(2):224-5. doi: 10.1161/CIRCGENETICS.113.000132. PubMed PMID:
23591041.
32: Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K. Enhanced
efficiency of human pluripotent stem cell genome editing through replacing TALENs
with CRISPRs. Cell Stem Cell. 2013 Apr 4;12(4):393-4. doi:
10.1016/j.stem.2013.03.006. PubMed PMID: 23561441; PubMed Central PMCID:
PMC3925309.
33: Musunuru K, Roden DM, Boineau R, Bristow MR, McCaffrey TA, Newton-Cheh C,
Paltoo DN, Rosenberg Y, Wohlgemuth JG, Zineh I, Hasan AA. Cardiovascular
pharmacogenomics: current status and future directions-report of a national
heart, lung, and blood institute working group. J Am Heart Assoc. 2012
Apr;1(2):e000554. doi: 10.1161/JAHA.111.000554. Epub 2012 Apr 24. PubMed PMID:
23130127; PubMed Central PMCID: PMC3487365.
34: Musunuru K. Transforming growth factor β2 mutations and familial thoracic
aortic aneurysms. Circ Cardiovasc Genet. 2012 Oct 1;5(5):593-4. doi:
10.1161/CIRCGENETICS.112.964858. PubMed PMID: 23074340.
35: Musunuru K. Induction of cardiomyocytes from cardiac fibroblasts. Circ
Cardiovasc Genet. 2012 Aug 1;5(4):481-2. doi: 10.1161/CIRCGENETICS.112.964288.
PubMed PMID: 22896018.
36: Musunuru K. Exome sequencing to identify novel genes in hypertension. Circ
Cardiovasc Genet. 2012 Apr 1;5(2):267-8. doi: 10.1161/CIRCGENETICS.112.963256.
PubMed PMID: 22511709.
37: Gupta RM, Musunuru K. Mapping Novel Pathways in Cardiovascular Disease Using
eQTL Data: The Past, Present, and Future of Gene Expression Analysis. Front
Genet. 2013 May 31;3:232. doi: 10.3389/fgene.2012.00232. eCollection 2012. PubMed
PMID: 23755065; PubMed Central PMCID: PMC3668154.
38: Musunuru K. Regulatory elements in noncoding DNA in the chromosome 9p21
locus. Circ Cardiovasc Genet. 2011 Jun;4(3):330-1. doi:
10.1161/CIRCGENETICS.111.960500. PubMed PMID: 21673313.
39: Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, Garimella
KV, Fisher S, Abreu J, Barry AJ, Fennell T, Banks E, Ambrogio L, Cibulskis K,
Kernytsky A, Gonzalez E, Rudzicz N, Engert JC, DePristo MA, Daly MJ, Cohen JC,
Hobbs HH, Altshuler D, Schonfeld G, Gabriel SB, Yue P, Kathiresan S. Exome
sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med.
2010 Dec 2;363(23):2220-7. doi: 10.1056/NEJMoa1002926. Epub 2010 Oct 13. PubMed
PMID: 20942659; PubMed Central PMCID: PMC3008575.
40: Musunuru K, Post WS, Herzog W, Shen H, O’Connell JR, McArdle PF, Ryan KA,
Gibson Q, Cheng YC, Clearfield E, Johnson AD, Tofler G, Yang Q, O’Donnell CJ,
Becker DM, Yanek LR, Becker LC, Faraday N, Bielak LF, Peyser PA, Shuldiner AR,
Mitchell BD. Association of single nucleotide polymorphisms on chromosome 9p21.3
with platelet reactivity: a potential mechanism for increased vascular disease.
Circ Cardiovasc Genet. 2010 Oct;3(5):445-53. doi:
10.1161/CIRCGENETICS.109.923508. Epub 2010 Sep 21. PubMed PMID: 20858905; PubMed
Central PMCID: PMC3031788.
41: Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, Li X,
Li H, Kuperwasser N, Ruda VM, Pirruccello JP, Muchmore B, Prokunina-Olsson L,
Hall JL, Schadt EE, Morales CR, Lund-Katz S, Phillips MC, Wong J, Cantley W,
Racie T, Ejebe KG, Orho-Melander M, Melander O, Koteliansky V, Fitzgerald K,
Krauss RM, Cowan CA, Kathiresan S, Rader DJ. From noncoding variant to phenotype
via SORT1 at the 1p13 cholesterol locus. Nature. 2010 Aug 5;466(7307):714-9. doi:
10.1038/nature09266. PubMed PMID: 20686566; PubMed Central PMCID: PMC3062476.
42: Musunuru K, Domian IJ, Chien KR. Stem cell models of cardiac development and
disease. Annu Rev Cell Dev Biol. 2010;26:667-87. doi:
10.1146/annurev-cellbio-100109-103948. Review. PubMed PMID: 20604707; PubMed
Central PMCID: PMC3955884.
43: Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, Stone EF,
Yuva-Paylor LA, Huber KM, Paylor R, Darnell JC, Darnell RB. A mouse model of the
human Fragile X syndrome I304N mutation. PLoS Genet. 2009 Dec;5(12):e1000758.
doi: 10.1371/journal.pgen.1000758. Epub 2009 Dec 11. PubMed PMID: 20011099;
PubMed Central PMCID: PMC2779495.
44: Sharma K, Blaha MJ, Blumenthal RS, Musunuru K. Clinical and research
applications of carotid intima-media thickness. Am J Cardiol. 2009 May
1;103(9):1316-20. doi: 10.1016/j.amjcard.2009.01.020. Epub 2009 Mar 13. PubMed
PMID: 19406278; PubMed Central PMCID: PMC2691892.
45: Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing
cardiovascular risk. Vasc Health Risk Manag. 2008;4(2):341-53. Review. PubMed
PMID: 18561510; PubMed Central PMCID: PMC2496987.
46: Musunuru K, Blumenthal RS. The implications of the ezetimibe and simvastatin
in hypercholesterolemia enhances atherosclerosis regression trial: a return to
first principles. Clin Cardiol. 2008 Jun;31(6):288-90. doi: 10.1002/clc.20405.
PubMed PMID: 18543313; PubMed Central PMCID: PMC6652859.
47: Musunuru K, Nasir K, Pandey S, Campbell CC, Carvalho JA, Meneghello R, Budoff
MJ, Blumenthal RS, Santos RD. A synergistic relationship of elevated low-density
lipoprotein cholesterol levels and systolic blood pressure with coronary artery
calcification. Atherosclerosis. 2008 Oct;200(2):368-73. doi:
10.1016/j.atherosclerosis.2007.12.015. Epub 2008 Feb 20. PubMed PMID: 18243213.
48: Musunuru K, Darnell RB. Determination and augmentation of RNA sequence
specificity of the Nova K-homology domains. Nucleic Acids Res. 2004 Sep
14;32(16):4852-61. Print 2004. PubMed PMID: 15367696; PubMed Central PMCID:
PMC519101.
49: Musunuru K. Cell-specific RNA-binding proteins in human disease. Trends
Cardiovasc Med. 2003 Jul;13(5):188-95. Review. PubMed PMID: 12837581.
50: Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, Darnell RB, Burley SK.
Sequence-specific RNA binding by a Nova KH domain: implications for
paraneoplastic disease and the fragile X syndrome. Cell. 2000 Feb
4;100(3):323-32. PubMed PMID: 10676814.
How will you feel about Dr. Musunuru after he takes out a restraining order on you?
No problem! I will turn it over to myn brother in law Bill. He si a thug who makes a living, shall we say, solving these problems. You should meet him.
Wrong, as usual. Not all who take umbrage with “The Ave” are Bill.
Funny thing about that. When I use VPN REVEAL, all these anonymous comments and efforts to hack THE-Ave and email addresses all come from the same VPN located in South Carolina! Amazing … even the ones that claim to come from Roberta Flack! Ms Flack’s security folks might well be interested since they helped ID this troll before. Well if anyone wants to know more o about this guy here is his web site https://www.linkedin.com/pulse/newest-webpage-d-is-for-diabetescom-william-quick?articleId=6289826881613160448#comments-
6289826881613160448&trk=public_profile_article_view